NCT01121549 2014-01-22
A Non-Interventional Study With AromasinĀ® As Adjuvant Treatment Of Invasive Early Breast Cancer
Pfizer
Terminated
Clinical Trials
5 trialsNCT00776659 2013-11-19
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
Pfizer
Terminated
NCT01239745 2012-10-31
AromasinĀ® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer
Pfizer
Terminated
NCT01155063 2012-10-01
Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
Pfizer
Terminated
NCT01305239 2012-04-10
ETAPE
Pfizer
Terminated